Projects per year
Personal profile
Education
- 慈濟大學醫學系學士
Experience
- 2016年01月 ~迄今 胸腔內科醫師
- 2015年08月 ~2015年12月 內科部斗六主治醫師
- 2013年08月 ~2015年07月 內科部住院醫師
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics where Po-Lan Su is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 3 Finished
-
評估奈米粒子搭載Osimertinib與FTY720在表皮生長因子受器突變且對Osimertinib抗藥肺癌的治療成效
Su, P.-L. (PI)
21-08-01 → 22-07-31
Project: Research project
-
-
評估標靶藥物合併FTY720和DG2的治療成效-針對表皮生長因子受器突變PD-1/PD-L1高表達肺癌
Su, P.-L. (PI)
19-08-01 → 20-07-31
Project: Research project
-
Early Acute Kidney Injury and Its Association With Survival in Patients With Metastatic Non-Small-Cell Lung Cancer Treated With Front-Line Immunotherapy-Based Therapies
Li, M., Su, P. L., Zhao, S., Cheng, G., Jones, N., Chian, K., Johns, N., Khorasanchi, A., Adeluola, A., Petouhoff, A., Spakowicz, D. J., Wei, L., Wang, X., Coss, C., Phelps, M. A., Meng, L., Yang, Y., Meara, A., Elsaid, M. I. & Gheeya, J. & 11 others, , 2025 Aug, In: Cancer medicine. 14, 15, e71058.Research output: Contribution to journal › Article › peer-review
Open Access -
Enhancing Lung Recovery: Inhaled Poly(lactic-co-glycolic) Acid Encapsulating FTY720 and Nobiletin for Lipopolysaccharide-Induced Lung Injury, with Advanced Inhalation Tower Technology
Zhang, H. H., Kuo, W. S., Tu, P. Y., Lee, C. T., Wang, H. C., Huang, Y. T., Shen, M. C., Lin, T. S., Su, P. L., Tsai, J. S., Pan, M. H., Lin, C. C. & Wu, P. C., 2025 Mar 4, In: ACS nano. 19, 8, p. 7634-7649 16 p.Research output: Contribution to journal › Article › peer-review
Open Access16 Link opens in a new tab Citations (Scopus) -
Increased Cardiovascular Risk With Lorlatinib in Patients With ALK-Mutated Lung Cancer: A Real-World Comparative Study
Lin, C. Y., Su, P. L., Kuo, C. W., Tsai, I. L., Liu, T. H., Yang, J., Lin, C. C. & Lin, S. H., 2025, In: Journal of the American Heart Association. 14, 24Research output: Contribution to journal › Article › peer-review
Open Access2 Link opens in a new tab Citations (Scopus) -
Multivariable model for predicting 5-year survival in patients with EGFR-mutated non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors: a retrospective study
Wang, Q. A., Tsai, I. L., Lin, C. Y., Su, P. L., Lin, C. C., Chang, J. W. C., Huang, C. Y., Fang, Y. F., Chang, C. F., Kuo, C. H. S., Hsu, P. C., Yang, C. T. & Wu, C. E., 2025 Jan 1, In: Therapeutic Advances in Medical Oncology. 17Research output: Contribution to journal › Article › peer-review
Open Access2 Link opens in a new tab Citations (Scopus) -
Phase 1 dose escalation trial of the selective adenosine A2B antagonist PBF-1129 in patients with metastatic non-small cell lung cancer
Owen, D. H., Wu, R., Wei, L., Dikov, M., Suman, S., Su, P. L., Amann, J., Guan, S., Spakowicz, D., Schweitzer, C., Pilcher, C., Smith, M. B., Ferguson, S., Palomino, J. C., Pérez, S. F., Bertino, E. M., Shields, P. G., He, K., Presley, C. J. & Otterson, G. A. & 2 others, , 2025 Dec, In: Investigational New Drugs. 43, 6, p. 1211-1221 11 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Link opens in a new tab Citation (Scopus)